Range
14.71 - 15.24
Vol / Avg.
21K/47.2K
Div / Yield
-
52 Wk
8.82 - 16.99
Mkt Cap
597.8M
Payout Ratio
-
Open
15.21
P/E
-
EPS
0.12
Shares
40.1M
Outstanding
40.1M
Total Float
4.6M
load more
Landos Biopharma Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of oral therapeutics for patients with autoimmune diseases. The LANCE platform identifies novel therapeutic targets based on predictions of immunometabolic function and creates therapeutic candidates to engage those targets in areas of unmet medical need.

Earnings

see more
Q3 2021Est.ActualSurprise
EPS
(EXPECTED)2021-12-08
REV
Q2 2021Est.ActualSurprise
EPS-0.3800.120 0.5000
REV18.000M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
LABPLandos Biopharma-1.32%597.8M

Landos Biopharma Questions & Anwsers

Q

How do I buy Landos Biopharma (LABP) stock?

A

You can purchase shares of Landos Biopharma (NASDAQ: LABP) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Landos Biopharma's (LABP) competitors?

A

There are no as such competitors for Landos Biopharma.

Q

What is the target price for Landos Biopharma (LABP) stock?

A

The latest price target for Landos Biopharma (NASDAQ: LABP) was reported by JonesTrading on September 23, 2021. The analyst firm set a price target for 39.00 expecting LABP to rise to within 12 months (a possible 161.74% upside). 6 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Landos Biopharma (LABP)?

A

The stock price for Landos Biopharma (NASDAQ: LABP) is $14.9 last updated Fri Sep 24 2021 20:00:02 GMT+0000 (Coordinated Universal Time).

Q

Does Landos Biopharma (LABP) pay a dividend?

A

There are no upcoming dividends for Landos Biopharma.

Q

When is Landos Biopharma (NASDAQ:LABP) reporting earnings?

A
Landos Biopharma’s Q3 earnings are confirmed for after-market on December 8, 2021.
Q

Is Landos Biopharma (LABP) going to split?

A

There is no upcoming split for Landos Biopharma.

Q

What sector and industry does Landos Biopharma (LABP) operate in?

A

Landos Biopharma is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.